微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 50.69% | -12.46% | -9.37% | 68/131 | 51.25% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 55.93% | -13.46% | -12% | 61/131 | 52.33% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 63.55% | -10.26% | -1.33% | 51/131 | 53.43% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 64.41% | -8% | 11.24% | 46/131 | 53.5% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 57.9% | -17.71% | -10.4% | 60/131 | 53.43% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 64.62% | -7.56% | -8.75% | 42/131 | 53.31% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 70.82% | -4.25% | 1.16% | 23/131 | 54.06% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 70.01% | -2.86% | -0.5% | 27/131 | 53.45% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 70.36% | -5.36% | 0.65% | 25/131 | 53.66% | 正海生物 | 89.78% | 行业排名> |
| 2022-12-31 | 69.91% | -3.36% | -5.48% | 26/131 | 53.83% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 73.96% | 2% | 2.63% | 20/131 | 55.13% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 72.06% | 2% | -0.37% | 24/131 | 54.78% | 三友医疗 | 90.29% | 行业排名> |
| 2021-12-31 | 72.34% | -6.26% | -2.7% | 29/131 | 57.29% | 三友医疗 | 90.73% | 行业排名> |
| 2021-03-31 | 74.35% | 2% | -3.66% | 24/131 | 60.75% | 三友医疗 | 90.5% | 行业排名> |
| 2020-12-31 | 77.17% | 14.02% | 14.02% | 23/131 | 59.59% | 三友医疗 | 90.29% | 行业排名> |
| 2019-12-31 | 67.68% | 0.7% | 0.7% | 42/131 | 56.37% | 正海生物 | 90.78% | 行业排名> |
| 2018-12-31 | 67.21% | 2% | 2% | 38/131 | 55.53% | 正海生物 | 91.59% | 行业排名> |